Sang-A Frontec Co.Ltd
Sang-A Frontec Co.,Ltd. engages in the research and development, production, and sale of materials/parts based on engineering plastics in South Korea and internationally. The company offers fuel cells; membranes, including vent filters and ePTFE for textiles, as well as membranes for medical use; semiconductor products, such as jar boxes, solar cassettes, FOUP products, wafer carriers, storage bo… Read more
Sang-A Frontec Co.Ltd (089980) - Total Liabilities
Latest total liabilities as of September 2025: ₩171.13 Billion KRW
Based on the latest financial reports, Sang-A Frontec Co.Ltd (089980) has total liabilities worth ₩171.13 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sang-A Frontec Co.Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Sang-A Frontec Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sang-A Frontec Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Sang-A Frontec Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Maschinenfabrik Berthold Hermle AG
F:MBH3
|
Germany | €142.00 Million |
|
Gyre Therapeutics Inc.
NASDAQ:GYRE
|
USA | $21.97 Million |
|
Jiangxi Everbright Measurement Cont
SHE:300906
|
China | CN¥102.03 Million |
|
Inhwa Precision Co. Ltd
KQ:101930
|
Korea | ₩131.24 Billion |
|
Aten International Co Ltd
TW:6277
|
Taiwan | NT$2.12 Billion |
|
Asia Polymer Corp
TW:1308
|
Taiwan | NT$1.82 Billion |
|
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
|
USA | $94.50 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Sang-A Frontec Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sang-A Frontec Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sang-A Frontec Co.Ltd (2011–2024)
The table below shows the annual total liabilities of Sang-A Frontec Co.Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩161.21 Billion | +3.39% |
| 2023-12-31 | ₩155.93 Billion | +3.28% |
| 2022-12-31 | ₩150.97 Billion | +9.43% |
| 2021-12-31 | ₩137.97 Billion | +3.48% |
| 2020-12-31 | ₩133.33 Billion | +27.57% |
| 2019-12-31 | ₩104.51 Billion | -12.79% |
| 2018-12-31 | ₩119.84 Billion | +8.51% |
| 2017-12-31 | ₩110.44 Billion | +6.63% |
| 2016-12-31 | ₩103.57 Billion | +17.42% |
| 2015-12-31 | ₩88.21 Billion | +25.16% |
| 2014-12-31 | ₩70.48 Billion | +11.70% |
| 2013-12-31 | ₩63.10 Billion | +38.54% |
| 2012-12-31 | ₩45.55 Billion | +12.39% |
| 2011-12-31 | ₩40.52 Billion | -- |